Copyright
©The Author(s) 2023.
World J Gastrointest Oncol. May 15, 2023; 15(5): 700-712
Published online May 15, 2023. doi: 10.4251/wjgo.v15.i5.700
Published online May 15, 2023. doi: 10.4251/wjgo.v15.i5.700
Figure 4 A case of poor response confirmed at pathology (ypT2N0).
A-C: A 42-year-old male with rectal cancer. Endoscopy (A) and MRI (B and C) staged a tumour of the middle rectum (cT3bN2, mesorectal fascia negative, extramural vascular invasion positive, pelvic nodes negative). The patient underwent total neoadjuvant therapy; D-F: Restaging at 20 wk after the beginning of neoadjuvant radiotherapy showed a poor response at endoscopy (D) and MRI (E and F).
- Citation: Cuicchi D, Castagna G, Cardelli S, Larotonda C, Petrello B, Poggioli G. Restaging rectal cancer following neoadjuvant chemoradiotherapy. World J Gastrointest Oncol 2023; 15(5): 700-712
- URL: https://www.wjgnet.com/1948-5204/full/v15/i5/700.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v15.i5.700